Good points, DDD, however my expectations of a readout from the 210 trial are tempered - I don't expect results until late 2018. If enrolment finishes this quarter, then we need to allow 18 weeks for the trial regimen, before collation of results. I think it will then take 2-3 months of analysis and peer review before conclusions can be published. If enrolment runs over this quarter's targeted deadline, it will be later. I would love it to be earlier but I'd rather be conservative with my expectations.
The good thing is that based on the pre-clinicals and P1 results, this looks like a true paradigm change in treatment that will be a watershed moment in clinical management of multiple disorders involving anxiety and depression. My mind boggles with the possibilities, and the $$s!
BNO Price at posting:
47.5¢ Sentiment: Hold Disclosure: Held
